![Hao Zhang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hao Zhang
Directeur/Membre du Conseil chez HaploX Investment Holding Ltd.
Postes actifs de Hao Zhang
Sociétés | Poste | Début | Fin |
---|---|---|---|
HaploX Investment Holding Ltd.
![]() HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Directeur/Membre du Conseil | 29/01/2023 | - |
Historique de carrière de Hao Zhang
Formation de Hao Zhang
Fudan University | Undergraduate Degree |
Tsinghua University | Graduate Degree |
Statistiques
Internationale
Chine | 3 |
Hong Kong | 2 |
Opérationnelle
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
HaploX Investment Holding Ltd.
![]() HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Commercial Services |